"Ottumwa Regional Health Center is a Health Center in Ottumwa, IA."

During the past decade, Ottumwa Regional Health Center conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 39 clinical trials were completed, i.e. on average, 243.8% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 20 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ottumwa Regional Health Center" #1 sponsor was "National Cancer Institute (NCI)" with 32 trials, followed by "SWOG Cancer Research Network" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NSABP Foundation Inc" with 4 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ottumwa Regional Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "NCIC Clinical Trials Group" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 3 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Ottumwa Regional Health Center" are "Recurrent Breast Carcinoma" (7 trials), "Recurrent Squamous Cell Lung Carcinoma" (6 trials), "Breast Cancer" (5 trials), "Stage IV Breast Cancer AJCC v6 and v7" (5 trials) and "HER2/Neu Negative" (4 trials). Many other conditions were trialed in "Ottumwa Regional Health Center" in a lesser frequency.

Most popular intervention types in "Ottumwa Regional Health Center" are "Drug" (47 trials), "Other" (45 trials), "Biological" (25 trials), "Procedure" (4 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (35 trials), "Bevacizumab" (12 trials), "Quality-of-Life Assessment" (11 trials), "Paclitaxel" (9 trials) and "Carboplatin" (7 trials). Other intervention names were less common.

The vast majority of trials in "Ottumwa Regional Health Center" are 44 trials for "All" genders and 10 trials for "Female" genders.

Currently, there are NaN active trials in "Ottumwa Regional Health Center". undefined are not yet recruiting, 3 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 24 completed trials in Ottumwa Regional Health Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ottumwa Regional Health Center, 0 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Ottumwa Regional Health Center has several departments that took part in Clinical trials: "McCreery Cancer Center at Ottumwa Regional" - 73 trials